Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid

BACKGROUND: Zoledronic acid is used to treat bone metastases and has been shown to reduce skeletal-related events and exert antitumor activity. The present in vitro study investigates the mechanism of action of Zoledronic Acid on breast cancer cell lines with different hormonal and HER2 patterns. Fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Toni, Mercatali, Laura, Sacanna, Emanuele, Tesei, Anna, Carloni, Silvia, Ulivi, Paola, Liverani, Chiara, Fabbri, Francesco, Zanoni, Michele, Zoli, Wainer, Amadori, Dino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519531/
https://www.ncbi.nlm.nih.gov/pubmed/23173568
http://dx.doi.org/10.1186/1475-2867-12-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519531/
https://www.ncbi.nlm.nih.gov/pubmed/23173568
http://dx.doi.org/10.1186/1475-2867-12-48

Ejemplares similares